Research has shed light on how a new type of antibody treatment reactivates patients’ immune cells to fight ovarian cancer.

The US Food and Drug Administration (FDA) has approved a pre-filled syringe version of argenx’s Vyvgart, giving generalised ...

Fintel reports that on April 22, 2025, UBS downgraded their outlook for Immunovant (NasdaqGS:IMVT) from Buy to Neutral.

Nika Beamon set out on a journey, and 26 doctors, 37 procedures and more than 17 years later, a rheumatologist finally ...

Several factors are associated with increased mortality in patients with bullous pemphigoid, with mortality rates increasing 5 years after diagnosis.

This study presents a valuable finding on the direct cytotoxic effects of DuoHexaBody-CD37 in diffuse large B-cell lymphoma, mediated via SHP-1 activation and antibody clustering, independent of ...

Invenra Inc., a leader in multispecific antibody discovery and development, today announced the launch of its B-Body Express™ Antibody Expression service. This new offering enables biotechnology and ...

Invenra Inc., a leader in multispecific antibody discovery and development, today announced the launch of its B-Body Expresstm Antibody Expression service. This new offering enables biotechnology and ...

The FDA has approved Uplizna (inebilizumab-cdon) for the treatment of immunoglobulin G4-related disease in adult patients.